000 01335 a2200361 4500
005 20250512235337.0
264 0 _c19830826
008 198308s 0 0 eng d
022 _a0002-9343
024 7 _a10.1016/0002-9343(83)91267-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBernstein, H N
245 0 0 _aOphthalmologic considerations and testing in patients receiving long-term antimalarial therapy.
_h[electronic resource]
260 _bThe American journal of medicine
_cJul 1983
300 _a25-34 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aChild
650 0 4 _aChloroquine
_xadverse effects
650 0 4 _aCiliary Body
_xdrug effects
650 0 4 _aCornea
_xdrug effects
650 0 4 _aDrug Administration Schedule
650 0 4 _aHumans
650 0 4 _aHydroxychloroquine
_xadverse effects
650 0 4 _aMacula Lutea
_xdrug effects
650 0 4 _aOphthalmoscopy
650 0 4 _aPhotoreceptor Cells
_xdrug effects
650 0 4 _aRetinal Diseases
_xchemically induced
650 0 4 _aVisual Fields
_xdrug effects
773 0 _tThe American journal of medicine
_gvol. 75
_gno. 1A
_gp. 25-34
856 4 0 _uhttps://doi.org/10.1016/0002-9343(83)91267-6
_zAvailable from publisher's website
999 _c6869142
_d6869142